N
Nnaemeka C. Iriemenam
Researcher at Centers for Disease Control and Prevention
Publications - 49
Citations - 991
Nnaemeka C. Iriemenam is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Malaria & Medicine. The author has an hindex of 17, co-authored 38 publications receiving 831 citations. Previous affiliations of Nnaemeka C. Iriemenam include Stockholm University & University of Lagos.
Papers
More filters
Journal ArticleDOI
A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis
TL;DR: Current and future chemotherapy strategies for the treatment of HAT are discussed and greater emphasis should be placed on the research and development of combination chemotherapies, based on the successful clinical tests with NECT and its current use as a frontline anti-trypanosomiasis treatment.
Journal ArticleDOI
Strongyloides stercoralis and the immune response.
TL;DR: The solution to reducing the prevalence of strongyloidiasis remains on the effectiveness of pre-emptive measures in endemic communities, increased awareness, prompt early diagnosis as well as timely treatment.
Journal ArticleDOI
Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya
Nnaemeka C. Iriemenam,Nnaemeka C. Iriemenam,Monica P. Shah,Monica P. Shah,Wangeci Gatei,Anna Maria van Eijk,Anna Maria van Eijk,John G. Ayisi,Simon Kariuki,Jodi Vanden Eng,Simon O. Owino,Ashima A. Lal,Ashima A. Lal,Yusuf Omosun,Yusuf Omosun,Kephas Otieno,Meghna Desai,Meghna Desai,Feiko O. ter Kuile,Feiko O. ter Kuile,Bernard L. Nahlen,Julie M. Moore,Mary J. Hamel,Peter Ouma,Laurence Slutsker,Ya Ping Shi +25 more
TL;DR: There was a significant increase in dhfr/dhps quintuple mutant and the emergence of new genotype containing dhps 581 in the parasites from pregnant women in western Kenya over 13 years, and further investigations are needed to determine the linkage between SP drug resistance markers and efficacy of IPTp-SP.
Journal ArticleDOI
Fc gamma receptor IIa (CD32) polymorphism and antibody responses to asexual blood-stage antigens of Plasmodium falciparum malaria in Sudanese patients
Amre Nasr,Amre Nasr,Nnaemeka C. Iriemenam,Nnaemeka C. Iriemenam,Marita Troye-Blomberg,Hayder A. Giha,Halima A. Balogun,O. F. Osman,Scott Montgomery,Scott Montgomery,Gehad ElGhazali,Klavs Berzins +11 more
TL;DR: The study revealed that the FcγRIIa‐R/R131 genotype is associated with the development of severe malaria, while the H/H131 genotypes is more likely to be associated with mild malaria.
Journal ArticleDOI
Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan
Nnaemeka C. Iriemenam,Atif H. Khirelsied,Amre Nasr,Amre Nasr,Gehad ElGhazali,Haider A. Giha,Thoraya M.E. A-Elgadir,Ahmed A. Agab-Aldour,Scott Montgomery,Scott Montgomery,Scott Montgomery,Robin F. Anders,Michael Theisen,Marita Troye-Blomberg,Mustafa I. Elbashir,Klavs Berzins +15 more
TL;DR: The results revealed a linear association with anti-AMA-1-IgG1 antibodies in children <5 years and reduced risk of severe malaria, while the responses of the IgG3 antibodies against MSP-2, M SP-3, GLURP in individuals above 5 years were bi-modal.